Background: Doxorubicin, an anthracycline class of anticancer, is an effective chemotherapeutic agent with serious adverse effects, mainly cardiotoxicity. Several possible causes of doxorubicin cardiotoxicity are increased oxidative stress, nucleic acid and protein synthesis inhibition, cardiomyocyte apoptosis, and mitochondrial biogenesis disruptions. (MO), a naturally derived medicine, is known for its antioxidative properties and activity in alleviating mitochondrial dysfunction.
View Article and Find Full Text PDF